In vitro-in vivo correlation in skin permeation

Pharmaceutical Research

Volumn 31, Issue 2, 2014, Pages 394-400

  Mohammed, D ^a   Matts, P J ^b   Hadgraft, J ^a   Lane, M E ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

confocal raman spectroscopy; in vitro in vivo correlation; niacinamide; permeation; skin

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ISOSORBIDE; MINERAL OIL; NICOTINAMIDE; PROPYLENE GLYCOL; SOLVENT;

ARTICLE; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SKIN PERMEABILITY; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FEMALE; HUMANS; ISOSORBIDE; LAURATES; MINERAL OIL; NIACINAMIDE; PERMEABILITY; PHARMACEUTICAL VEHICLES; PROPYLENE GLYCOL; PROPYLENE GLYCOLS; PYRROLIDINONES; SKIN; SKIN ABSORPTION; SOLUBILITY; SOLVENTS;

EID: 84896690120     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1169-2     Document Type: Article

References (27)

1. Franz TJ, Lehman, Raney SG. Use of excised human skin to assess the bioequivalence of topical products. Skin Pharmacol Physiol. 2009;22:276-86.
2. Lehman PA, Raney SG, Franz TJ. Percutaneous absorption in man: in vitro-in vivo correlation. Skin Pharmacol Physiol. 2011;24:24-30.
3. Caspers PJ, Lucassen GW, Wolthuis R, Bruining HA, Puppels GJ. In vitro and in vivo Raman spectroscopy of human skin. Biospectroscopy. 1998;4:S31-9.
4. Caspers PJ, Lucassen GW, Bruining HA, Puppels GJ. Automated depth-scanning confocal Raman microspectrometer for rapid in vivo determination of water concentration profiles in human skin. J Raman Spectrosc. 2000;31:813-8.
5. Mateus R, Abdalghafor H, Oliveira G, Hadgraft J, Lane ME. A new paradigm in dermatopharmacokinetics - Confocal Raman spectroscopy. Int J Pharm. 2013;444:106-8.
6. Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26:231-8.
7. Bissett DL, Oblong JE, Berge CA. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31:860-5.
8. Kimball AB, Kaczvinsky JR, Li J, Robinson LR, Matts PJ, Berge CA, et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial. Br J Dermatol. 2010;162:435-41.
9. Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons: in pharmaceuticals, body fluids and postmortem material, Volume 2. Pharmaceutical Press and American Pharmacists' Association. 2004. p. 1333.
10. Nicoli S, Zani F, Bilzi S, Bettini R, Santi P. Association of nicotinamide with parabens: effect on solubility, partition and transdermal permeation. Eur J Pharm Biopharm. 2008;69:613-21.
11. Dias M, Hadgraft J, Lane ME. Influence of membrane-solvent-solute interactions on solute permeation in skin. Int J Pharm. 2007;340:65-70.
12. Dias M, Hadgraft J, Lane ME. Influence of membrane-solvent-solute interactions on solute permeation in model membranes. Int J Pharm. 2007;336:108-14.
13. Van Krevelen DW, Hoftyzer PJ, editors. Properties of polymers, their estimation and correlation with chemical structure. Amsterdam: Elsevier; 1976. p. 129-59.
14. Watkinson RM, Herkenne C, Guy RH, Hadgraft J, Oliveira G, Lane ME. Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin. Skin Pharmacol Physiol. 2009;22:15-21.
15. Oliveira G, Beezer AE, Hadgraft J, Lane ME. Alcohol enhanced permeation in model membranes. Part II. Thermodynamic analysis of membrane partitioning. Int J Pharm. 2011;420:216-22.
16. Mohammed D, Matts PJ, Hadgraft J, Lane ME. Influence of Aqueous Cream BP on corneocyte size, maturity, skin protease activity, protein content and transepidermal water loss. Br J Dermatol. 2011;164:1304-10.
17. Tarantino R, Bishop E, Chen F-C, Iqbal K, Malick AW. N-methyl-2- pyrrolidone as a cosolvent: Relationship of cosolvent effect with solute polarity and the presence of proton-donating groups on model drug compounds. J Pharm Sci. 1994;83:1213-6.
18. Liron Z, Cohen S. Percutaneous absorption of alkanoic acids II: Application of regular solution theory. J Pharm Sci. 1984;73:538-42.
19. Gwak H, Kim S, Chun I. Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin. Arch Pharm Res. 2002;25:392-6.
20. Lee PJ, Langer R, Shastri VP. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci. 2005;94:912-7.
21. Otto A, Wiechers JW, Kelly CL, Hadgraft J, Du Plessis J. Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients. Skin Pharmacol Physiol. 2008;21:326-34.
22. Watkinson RM, Guy RH, Hadgraft J, Lane ME. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation. Skin Pharmacol Physiol. 2009;22:225-30.
23. Watkinson RM, Guy RH, Oliveira G, Hadgraft J, Lane ME. Optimisation of cosolvent concentration for topical drug delivery III-influence of lipophilic vehicles on ibuprofen permeation. Skin Pharmacol Physiol. 2011;24:22-6.
24. Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447:12-21.
25. Caspers PJ, Williams AC, Carter EA, Edwards HG, Barry BW, Bruining HA, et al. Monitoring the penetration enhancer dimethyl sulfoxide in human stratum corneum in vivo by confocal Raman spectroscopy. Pharm Res. 2002;19:1577-80.
26. Berner B, Mazzenga GC, Otte JH, Steffens RJ, Juang RH, Ebert CD. Ethanol: water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. J Pharm Sci. 1989;78:402-7.
27. Trottet L, Merly C, Mirza M, Hadgraft J, Davis AF. Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int J Pharm. 2004;274:213-9.